Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Assets
Cash and cash equivalents	$ 145,995	$ 151,168
Accounts receivable, net of allowance for credit losses	108,540	108,079
Financing receivables, net of allowance for credit losses	121,325	121,954
Variable consideration receivables, net of allowance for credit losses	90,624	91,402
Inventories	35,823	32,505
Prepaid expenses	16,663	14,881
Film assets, net of accumulated amortization	16,638	15,529
Property, plant and equipment, net of accumulated depreciation	240,890	242,910
Lease incentives and other assets	27,240	24,820
Deferred income tax assets, net of valuation allowance	12,675	12,577
Goodwill	45,815	45,815
Other intangible assets, net of accumulated amortization	30,923	32,391
Total assets	893,151	894,031
Liabilities
Accounts payable	17,193	19,478
Accrued and other liabilities	88,138	105,293
Deferred revenue	56,132	50,395
Revolving credit facility borrowings, net of unamortized debt issuance costs	46,702	34,577
Convertible notes and other borrowings, net of unamortized discounts and debt issuance costs	244,128	244,034
Deferred income tax liabilities	12,521	12,521
Total liabilities	464,814	466,298
Commitments, contingencies and guarantees (see Note 7)
Non-controlling interests	691	666
Shareholders’ equity
Capital stock common shares — no par value. Authorized — Unlimited number. 54,855,176 issued and outstanding (December 31, 2025 — 53,921,676 issued and outstanding)	429,650	419,162
Other equity	145,998	164,782
Statutory surplus reserve	4,219	4,219
Accumulated deficit	(235,741)	(239,967)
Accumulated other comprehensive loss	(8,664)	(10,305)
Total shareholders’ equity attributable to common shareholders	335,462	337,891
Non-controlling interests	92,184	89,176
Total shareholders’ equity	427,646	427,067
Total liabilities and shareholders’ equity	$ 893,151	$ 894,031